Vor Biopharma Inc.
- VOR
- NASDAQ
- Biotechnology
- Cancer Cell Therapy
- Stem Cell Engineering
$18.03
Today −6.77%Quote Oct 16, 2026, 08:00 PM UTC
−17.63%over the last month
Max drawdown −18.0%From 1-month high −18.0%3 months +3.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$977.0M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$27.00
+49.8% from here
Floor
$16.93
6.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VORPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
76